Articles from Penfund Management Ltd.

TORONTO, March 04, 2026 (GLOBE NEWSWIRE) -- Penfund, an independent provider of capital to North American middle market companies, announced the completion of a US$205 million unitranche loan to DOCS Dermatology Group (“DOCS” or the “Company”), a portfolio company of SkyKnight Capital (“SkyKnight”).

TORONTO, April 22, 2025 (GLOBE NEWSWIRE) -- Penfund is pleased to announce the final close of its new senior debt fund, Penfund Prime (“Prime”). Prime will deploy $1.8 billion (USD) of investable capital into unitranche and senior term loans issued by North American borrowers. Seven investments have been completed to date and Prime is actively reviewing new opportunities to support market leading private equity firms and borrowers.

TORONTO, June 26, 2024 (GLOBE NEWSWIRE) -- Penfund is pleased to announce the first close of its new senior debt fund, Penfund Prime (“Prime”). Prime will provide unitranche and senior term loans to middle market North American borrowers. Penfund will leverage 25+ years of experience investing in best-in-class businesses within the automotive aftermarket, financial services, healthcare, distribution and consumer staple sectors. The new strategy will complement Penfund’s existing junior capital platform by expanding the range of capital solutions available to borrowers.

TORONTO, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Penfund, an independent provider of junior capital to North American middle market companies, announced the completion of a C$70 million subordinated debt investment in CBI Health Group (“CBIH” or the “Company”), a portfolio company of OMERS Private Equity (“OMERS”). Penfund acted as lead lender and agent for the subordinated debt facility, which supported a comprehensive refinancing of CBIH’s existing credit facilities.

TORONTO, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Penfund, an independent provider of junior capital to North American middle market companies, announced the completion of a unitranche debt investment in Recochem, Inc. (“Recochem” or the “Company”). Penfund served as a Joint Lead Arranger and Joint Bookrunner on the financing, which supported the acquisition of Recochem by funds managed by CapVest Partners LLP (“CapVest”).

TORONTO, Dec. 14, 2022 (GLOBE NEWSWIRE) -- Penfund announced today that it recently completed the final close of its seventh fund, Penfund Capital Fund VII, with committed capital of approximately $1.6 billion (CDN). This amount exceeds Fund VII’s original fundraising target of $1.5 billion (CDN). Penfund is grateful for the consistent support of its long-standing investment partners and is delighted to have established new relationships with a number of leading global investors.